Abraham Ceesay sold $2.4M of Rapport Therapeutics (RAPP)

Executed Aug 10, disclosed Aug 12, 2 days later.

Value, as filed

$2.4M

51,499 sh across 5 lots

Executed

Aug 10

the trade date, as filed

Disclosed

Aug 12

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Abraham Ceesay Chief Executive Officer profile →

Abraham Ceesay (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.4M of RAPP (51,499 sh across 5 lots, as filed), executed Aug 10.

The name

RAPP

Rapport Therapeutics, Inc. RAPP · Healthcare · 32 filings in 24 months ticker →

Healthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Abraham Ceesay in RAPP

RAPPSALE Rapport Therapeutics, Inc. $325K
7,141 sh × $45.55
Exec Sep 8
Filed Sep 9 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. $938K
18,921 sh × $49.57
Exec Aug 25
Filed Aug 26 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. $328K
8,210 sh across 2 lots
Exec Jul 14
Filed Jul 15 · 4:15 PM ET RAPPSALE Rapport Therapeutics, Inc. $292K
7,344 sh × $39.77
Exec Jun 29
Filed Jul 1 · 4:05 PM ET RAPPSALE Rapport Therapeutics, Inc. $103K
3,552 sh × $29.05
Exec Feb 18
Filed Feb 19 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $285K
10,916 sh across 2 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $231K
8,975 sh across 2 lots
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $2.0M
74,320 sh across 2 lots
Exec Sep 17 2025
Filed Sep 19 2025 · 5:30 PM ET